Inclusion Body Myositis With Dr. Elie Naddaf

Inclusion Body Myositis With Dr. Elie Naddaf

Up next

April 2026 Multiple Sclerosis and Related Disorders Issue With Dr. Andrew J. Solomon

In this episode, Lyell K. Jones Jr, MD, FAAN, speaks with Andrew J. Solomon, MD, FAAN, who served as the guest editor of the April 2026 Multiple Sclerosis and Related Disorders issue. They provide a preview of the issue, which publishes on April 2, 2026. Dr. Jones is the editor-i ...  Show more

Neurologic Complications of Drug and Alcohol Use With Dr. Adeline L. Goss

Neurologic complications of substance use may be the first symptoms that lead patients with substance use disorders to seek care. Neurologists have a key role in identifying patients with substance use disorders and connecting them to treatment. In this episode, Lyell K. Jones Jr ...  Show more

Recommended Episodes

Vitreopapillary Findings in Nonarteritic Ischemic Optic Neuropathy
Ophthalmology Journal

Dr. Drew Carey speaks with Dr. Tongalp H. Tezel on his study comparing patients with nonarteritic ischemic optic neuropathy (NAION) with healthy non-NAION patients with crowded discs and noncrowded optic discs. From his Ophthalmology article, "

  Show more

Ocular Manifestations of ROSAH Syndrome
Ophthalmology Journal

What is ROSAH syndrome and how does it affect the visual function of patients with it? Dr. Tsui discusses this with Drs. Laryssa A. Huryn and Shilpa Kodati, authors of the Ophthalmology article, "<a href= "https://www.aaojournal.org/article/S0161-642 ...

  Show more

Semaglutide and NAION
Experts InSight

Dr. Peter Quiros joins host Dr. Amanda Redfern to discuss the recent JAMA Ophthalmology article "The Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide," the first study to report a possible association between semaglutide (Wegovy, Ozempic, ...  Show more

Novel Therapies in GI Oncology at ASCO23
ASCO Daily News

Drs. Shaalan Beg and Shiraj Sen discuss notable advances in GI cancers featured at the 2023 ASCO Annual Meeting, including the PROSPECT and PRODIGE-23 trials in rectal adenocarcinoma, the MORPHEUS study in uHCC, and the NORPACT-1 trial in pancreatic head cancer.

<span s ...

  Show more